Craig Adam R - Insider Non-Derivative Transactions at CTI BIOPHARMA CORP (CTIC) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jun 26, 2023, Craig Adam R's relationship to CTI BIOPHARMA CORP (CTIC) is Director,Officer (President and CEO), and currently has 0 shares of common stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CTIC insiders.

Data Source: SEC.
Craig Adam R - Insider Non-Derivative Transactions of CTIC common stock
Craig Adam R - Insider Non-Derivative Transactions at CTIC
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jun 27, 2023 U -- (Common Stock) 31470 9.1 0
Jan 25, 2023 Sell -- (common stock) 2117 6.01 29440
Jan 25, 2023 Sell -- (common stock) 83200 6 29440
Jan 25, 2023 M -- (common stock) 2117 0.84 31557
Jan 25, 2023 M -- (common stock) 83200 0.84 112640
Jan 4, 2023 Sell -- (common stock) 84683 6.01 29440
Jan 4, 2023 M -- (common stock) 84683 0.84 114123
Dec 31, 2022 Sell -- (common stock) 4400 6.01 29440
Dec 31, 2022 Sell -- (common stock) 700 6.01 29440
Dec 31, 2022 Sell -- (common stock) 12000 6 29440
Dec 31, 2022 Acquisition -- (common stock) 1579 5.11 29440
Dec 31, 2022 M -- (common stock) 700 0.84 30140
Dec 31, 2022 M -- (common stock) 4400 0.84 33840
Dec 31, 2022 M -- (common stock) 12000 0.84 41440
Dec 30, 2022 Sell -- (common stock) 13800 6 27861
Dec 30, 2022 M -- (common stock) 13800 0.84 41661